NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD
57.56
+1.06 (+1.88%)
The current stock price of HOLX is 57.56 USD. In the past month the price decreased by -5.65%. In the past year, price decreased by -23.64%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.4 | 227.16B | ||
ISRG | INTUITIVE SURGICAL INC | 65.86 | 172.95B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.9 | 140.69B | ||
SYK | STRYKER CORP | 28.42 | 132.26B | ||
MDT | MEDTRONIC PLC | 15.47 | 105.94B | ||
BDX | BECTON DICKINSON AND CO | 14.29 | 57.06B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.3 | 42.05B | ||
IDXX | IDEXX LABORATORIES INC | 36.58 | 33.35B | ||
RMD | RESMED INC | 24.08 | 31.27B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 13.89 | 28.52B | ||
DXCM | DEXCOM INC | 41.56 | 26.89B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.04 | 22.19B |
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752 US
CEO: STEPHEN P. MACMILLAN
Employees: 6990
Company Website: https://www.hologic.com/
Investor Relations: https://investors.hologic.com
Phone: 15082632900
The current stock price of HOLX is 57.56 USD. The price increased by 1.88% in the last trading session.
The exchange symbol of HOLOGIC INC is HOLX and it is listed on the Nasdaq exchange.
HOLX stock is listed on the Nasdaq exchange.
28 analysts have analysed HOLX and the average price target is 80.47 USD. This implies a price increase of 39.81% is expected in the next year compared to the current price of 57.56. Check the HOLOGIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HOLOGIC INC (HOLX) has a market capitalization of 12.92B USD. This makes HOLX a Large Cap stock.
HOLOGIC INC (HOLX) currently has 6990 employees.
HOLOGIC INC (HOLX) has a resistance level at 63.18. Check the full technical report for a detailed analysis of HOLX support and resistance levels.
The Revenue of HOLOGIC INC (HOLX) is expected to grow by 1.61% in the next year. Check the estimates tab for more information on the HOLX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HOLX does not pay a dividend.
HOLOGIC INC (HOLX) will report earnings on 2025-05-01, after the market close.
The PE ratio for HOLOGIC INC (HOLX) is 13.94. This is based on the reported non-GAAP earnings per share of 4.13 and the current share price of 57.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for HOLX.
The outstanding short interest for HOLOGIC INC (HOLX) is 2% of its float. Check the ownership tab for more information on the HOLX short interest.
ChartMill assigns a fundamental rating of 6 / 10 to HOLX. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months HOLX reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS increased by 6.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.42% | ||
ROA | 8.52% | ||
ROE | 15.59% | ||
Debt/Equity | 0.52 |
ChartMill assigns a Buy % Consensus number of 70% to HOLX. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 6.52% and a revenue growth 1.61% for HOLX